Neumora Therapeutics, Inc.
NMRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001885522
In the last 90 days, Neumora Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $129.2M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $701.6K in total
- 2
- 13F holdersQ2 2026, 0 vs. previous quarter
- 113
- 13F valueReported value at the end of Q2 2026
- $129.2M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NMRA, Q2 2026
No superinvestor reported holding NMRA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Neumora Therapeutics, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)7:10 PM ET | Aug 20-21 | 1 day | Aurora Daljit SinghSee Remarks | SSale | −88.3K | $1.53 | −$135.4K | −64.4%48.8K after | 2 lots |
| Aug 21, 2026 (view filing)7:10 PM ET | Aug 20-21 | 1 day | Aurora Daljit SinghSee Remarks | SSale | −87.8K | $1.53 | −$134.6K | −100.0%0 after | 2 lots |
| Aug 19, 2026 (view filing)7:17 PM ET | Aug 17-19 | 2 days | Aurora Daljit SinghSee Remarks | SSale | −156.9K | $1.55 | −$242.5K | −76.3%48.8K after | 4 lots |
| Aug 19, 2026 (view filing)7:17 PM ET | Aug 17-19 | 2 days | Aurora Daljit SinghSee Remarks | SSale | −120.9K | $1.56 | −$189.2K | −100.0%0 after | 3 lots |
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Aurora Daljit SinghSee Remarks | SSale | −6.17K | $3.56 | −$21.9K | −6.9%82.8K after | |
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Pinto JoshuaPresident | SSale | −5.97K | $3.54 | −$21.1K | −9.4%57.8K after | |
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Berns Paul LSee Remarks | SSale | −9.82K | $3.51 | −$34.5K | −0.1%7.40M after | |
| Feb 19, 2026 (view filing) | Feb 17 | 2 days | Milligan Michael LeeSee Remarks | SSale | −1.44K | $3.57 | −$5.13K | −6.4%21.0K after | 10b5-1 |
| Nov 13, 2025 (view filing) | Nov 11 | 2 days | Aurora Daljit SinghSee Remarks | SSale | −114.7K | $2.68 | −$307.4K | −100.0%0 after | 10b5-1 |
| Oct 29, 2025 (view filing)7:21 PM ET | Oct 27 | 2 days | Crandell Keith and 6 others10% Owner | PPurchase | +1.92M | $2.61 | +$5.00M | +46.4%6.05M after | Duplicate filing |
Top 10 13F holders, Q2 2026
The largest institutional positions in Neumora Therapeutics, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Siren, L.L.C. | 8,497,822 | $14.4M | 0.29% | 00.0% | Unchanged |
| BlackRock, Inc. | 7,791,869 | $13.2M | 0.00% | +5,737,553+279.3% | Added |
| Softbank Group Corp | 6,090,301 | $10.4M | 0.06% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 4,669,585 | $7.94M | 0.00% | +777,692+20.0% | Added |
| MIC Capital Management UK LLP | 4,460,700 | $7.58M | 1.92% | 00.0% | Unchanged |
| FMR LLC | 3,498,869 | $5.95M | 0.00% | +2110.0% | Added |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 3,309,123 | $5.63M | 0.06% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 2,607,289 | $4.43M | 0.00% | +1,520,424+139.9% | Added |
| ICONIQ Capital, LLC | 2,559,090 | $4.35M | 0.13% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 2,244,829 | $3.82M | 0.00% | +208,137+10.2% | Added |